US and European pharma groups benefit from cash-rich Chinese sector seeking new medicines
Related Posts
‘Invisible hand’ pulls up the handbrake on Xi’s pet project
Elite business schools in China braced for intervention
DST Global Co-Leads $32M Series C Round In Mobile App Tantan
China, America and the road to a new world order
Outsourcing center aims to help firms tap services
China and Russia sign gas deal
Alibaba and other companies addition to U.S. “notorious market list” angers China
Trump tells economic chiefs to consider rejoining trade pact
Crackdown propels rare earth prices
China factory activity slowest since 2012